This company listing is no longer active
PSYB.H Stock Overview
A biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
PsyBio Therapeutics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.005 |
| Beta | 0.63 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -60.00% |
| 3 Year Change | -97.22% |
| 5 Year Change | n/a |
| Change since IPO | -98.36% |
Recent News & Updates
Shareholder Returns
| PSYB.H | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | 1.5% |
| 1Y | -60.0% | 13.3% | 10.8% |
Return vs Industry: PSYB.H underperformed the Canadian Biotechs industry which returned -36.6% over the past year.
Return vs Market: PSYB.H underperformed the Canadian Market which returned 10.4% over the past year.
Price Volatility
| PSYB.H volatility | |
|---|---|
| PSYB.H Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 12.6% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.3% |
Stable Share Price: PSYB.H has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PSYB.H's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Evan Levine | www.psybiolife.com |
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.
PsyBio Therapeutics Corp. Fundamentals Summary
| PSYB.H fundamental statistics | |
|---|---|
| Market cap | CA$1.33m |
| Earnings (TTM) | -CA$2.63m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs PSYB.H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PSYB.H income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$50.00k |
| Gross Profit | -US$50.00k |
| Other Expenses | US$1.85m |
| Earnings | -US$1.90m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did PSYB.H perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/30 17:28 |
| End of Day Share Price | 2024/07/26 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PsyBio Therapeutics Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert LeBoyer | NOBLE Capital Markets, Inc. |